Atlas Trials

Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis

Clinical trial NCT00418847 · COMPLETED

Trial details

NCT number
NCT00418847
Sponsor
The Hospital for Sick Children
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gangliosidoses GM2
Start date
2004-07-01
Primary completion
2009-04-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.